TORL BioTherapeutics, LLC
Dave Licata is an experienced executive in the biotechnology and pharmaceutical sectors, holding prominent positions such as President and CFO of TORL BioTherapeutics and Executive Chairman of 1200 Pharma. Dave has also served as President and CEO at both 1200 Pharma and TORL BioTherapeutics, as well as Founder and Chairman of the Board at Holoclara. Additionally, Dave has contributed as an Entrepreneur in Residence at Caltech. Academic credentials include a Bachelor of Science and a Master of Science in Mechanical Engineering from Stanford University.
This person is not in any offices
TORL BioTherapeutics, LLC
1 followers
A clinical-stage biopharmaceutical company advancing the development of new biologics for cancer treatment. TORL-Bio was founded in 2018 and is focused on the development of novel antibody-based therapeutics for cancer patients. TORL has currently 3 therapeutics in Ph1 clinical trials in indications such as NSCLC, gastric, pancreatic and ovarian cancers